期刊文献+

丝氨酸/苏氨酸蛋白磷酸酶1/2A在缺氧预处理诱导人脐静脉内皮细胞耐受中的作用(英文)

Involvement of serine/threonine protein phosphatases 1/2A in tolerance established by hypoxic preconditioning in human umbilical vein endothelial cells
下载PDF
导出
摘要 目的研究丝氨酸/苏氨酸蛋白磷酸酶1/2A(PP1/2A)在调节人脐静脉内皮细胞(HUVEC)对缺氧耐受相关信号转导中的作用。方法采用缺氧预处理诱导HUVEC对缺氧损伤的耐受。采用细胞存活率、乳酸脱氢酶(LDH)释放及总抗氧化能力(T-AOC)评价HUVEC的耐受性。免疫细胞化学联合蛋白质印迹法检测核因子E2相关因子2(Nrf2)的亚细胞定位。蛋白质印迹法检测应激蛋白血红素氧合酶1(HO-1)的表达。结果缺氧90 min导致HUVEC存活率及T-AOC降低,LDH释放增加。缺氧预处理(缺氧10 min后4, 8及24 h)可提高HUVEC对随后缺氧90 min的耐受,细胞存活率及T-AOC较缺氧组显著提高,LDH释出显著降低,并诱导Nrf2由胞浆向胞核移位,上调其下游信号分子HO-1的表达。缺氧预处理前用PP1/2A特异性抑制剂冈田酸(40 nmol.L-1)孵育HUVEC 10 min可部分抑制缺氧预处理诱导的Nrf2向核移位、HO-1表达及细胞耐受性。结论 PP1/2A至少部分参与缺氧预处理诱导HUVEC对缺氧损伤的耐受,其机制可能与调节Nrf2向核移位及HO-1表达有关。 AIM To investigate the role of serine/ threonine protein phosphatases 1 and 2A (PP1/2A) in regulation of cell signal transduction involved in the tolerance of human umbilical vein endothelial ceils (HUVEC) to hypoxia. METHODS HUVEC tolerance was established by hypoxic preconditioning. The tolerance of HUVEC was evaluated by the cell survival rate, lactic dehydrogenase (LDH) releasing and total antagonistic-oxidative capability ( T-AOC ). Subcellular localization of nuclear factor E2-related factor 2 (Nrf2) was determined by immunocytochemistry combined with Westem blot. The expression of stress protein of heme oxygenase-1 (HO-1) was measured by Westem blot. RESULTS Hypoxia 90 min decreased the survival rate and T-AOC of HUVEC significantly, increased the release of LDH in cultured HUVEC. Compared with the hypoxic group, hypoxic preconditioning (4, 8 and 24 h after hypoxia 10 min) up-regulated the tolerance against hypoxia in HUVEC, the survival rate of HUVEC and T-AOC increased and the release of LDH down-regulated when insulted with hypoxia (90 min) in HUVEC. Hypoxic preconditioning established the translocation of Nrf2 from cytoplasm to nucleus and up-regulated the expression of downstream protein HO-1. Pretreatment with okadaic acid (40 nmol·L^-1 ), a powerful inhibitor of PP1/2A, for 10 min in hypoxic preconditioning HUVEC partly inhibited the translocation of Nrf2 from cytoplasm to nucleus and the expression of HO-1, abolished the tolerance of HU- VEC established by hypoxic preconditioning. CON CLUSION PP1/2A at least partly take part in regulation of translocation of Nrf2 and expression of HO-1, which is associated with the tolerance of HUVEC established by hypoxic preconditioning.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2008年第1期9-16,共8页 Chinese Journal of Pharmacology and Toxicology
基金 国家基础研究发展规划项目(2005CB522601)~~
关键词 磷蛋白磷酸酶 内皮 血管 细胞 培养的 预处理 低氧 核因子E2相关因子2 血红素氧化酶 冈田酸 phosphoprotein phosphatase endothelium, vascular ceils, cultured preconditioning, hypoxia nuclear factor E2-related factor 2 heme oxygenase okadaic acid
  • 相关文献

参考文献10

  • 1Laude K, Beauchamp P, Thuillez C, Richard V. Endothelial protective effects of preconditioning[ J ]. Cardiovasc Res, 2002, 55(3) :466 -473.
  • 2Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism [ J ]. J Biochem Mol Biol, 2004, 37(2) :139 - 143.
  • 3Tiligada E, Papamichael K, Vovou I, Delitheos A. Circumvention of camptothecin-induced resistance during the adaptive cellular stress response [ J ]. Anticancer Res, 2006, 26(1A) :421 -425.
  • 4Fenton RA, Dickson EW, Dobson JG Jr. Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart [J]. Life Sci, 2005, 77(26):3375 -3388.
  • 5陈炜,吴志勇,邱江锋,罗海峰,张志奇,Joan Rosello-Catafau.缺血预处理对肝细胞缺血再灌氧损伤的影响[J].肝胆外科杂志,2005,13(2):153-154. 被引量:1
  • 6Pohlman TH, Harlan JM. Adaptive responses of the endothelium to stress[J]. J Surg Res, 2000, 89(1) :85 -119.
  • 7Fernandez P, Guillen MI, Gomar F, Alcaraz MJ. Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes [ J ]. Biochem Pharmacol, 2003, 66(10) :2049 -2052.
  • 8Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, et al. Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects [ J ]. J Pharmacol Exp Ther, 2006, 319 (3) :1144 - 1152.
  • 9Ladilov Y, Maxeiner H, Wolf C, Schafer C, Meuter K, Piper HM. Role of protein phosphatases in hypoxic pre- conditioning [ J ]. Am J Physiol Heart Circ Physiol, 2002, 283(3) :H1092 - H1098.
  • 10Haystead TA, Sim AT, Carling D, Honnor RC, Tsukitani Y, Cohen P, et al. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism[J]. Nature, 1989, 337(6202) :78 -81.

二级参考文献8

  • 1Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemiareperfusion: role of nitric oxide and adenosine [J]. Hepatology,1997,25:934-937.
  • 2Yoshizumi T, Yanaga K, Soejima Y,et al. Amelioration of the liver injury by ischemic preconditioning [J]. Br J Surg, 1998,85 :1636-1640.
  • 3Seglen PO. Preparation of rat liver cells. III. Enzymaticrequirements for tissue dispersion[J]. Exp Cell Res, 1973,82 : 391-398.
  • 4Berry MN,Friend DS. High-yield preparation of isolate rat live rparenchymal cells, a biochemicaland fine structural study[J]. J Cell Biol, 1969,43 : 506-520.
  • 5Camargo CA, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent [J]. Hepatology, 1997,26 :1513-1520.
  • 6Murry CE, Jenning RB, Reimer KA, et al. Preconditioning with ischemia :a delay of lethal cell injury in ischemic myocardium[J].Circulation, 1986,74 = 1124 - 1136.
  • 7Yellon DM, Baxter GF, Garcia-Dorado D, et al. Ischemic preconditioning: present position and future directions [J].Cardiovasc Res, 1998,37: 21-33.
  • 8Parrat J. Protection of the heart by ischemic preconditioning and possibilities for pharmacological exploitation [J]. Trends in Pharmacological Science, 1994,15:19-25.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部